Xin Han
Biochemistry, Genetics and Molecular Biology · University of Michigan
Publications
71
Citations
3,043
Est. group size
~3
Recurring co-author estimate
Active years
27
Publishing since 2000
Typically publishes in teams of ~8 · 16% small-team papers (≤3 authors) · across 28 venues
- Discovery of a First‐in‐Class Murine Double Minute 2‐Recruiting Positive Transcription Elongation Factor B PROTAC Degrader With Selective Antitumor Activity
MedComm · 2026
- Copper-Catalyzed Asymmetric C–H Sulfilimination of Arenes via HAT-Primed C–S Radical–Radical Coupling
Journal of the American Chemical Society · 2025
- In silico modeling of targeted protein degradation
European Journal of Medicinal Chemistry · 2025
- Proteome‐Wide Data Guides the Discovery of Lysine‐Targeting Covalent Inhibitors Using DNA‐Encoded Chemical Libraries
Angewandte Chemie International Edition · 2025
- Discovery of dCDK9-202 as a Highly Potent and Selective PROTAC CDK9 Degrader with Strong <i>In Vivo</i> Antitumor Activity
Journal of Medicinal Chemistry · 2025
- Exploiting targeted degradation of cyclins and cyclin-dependent kinases for cancer therapeutics: a review
Journal of Zhejiang University SCIENCE B · 2025
- PROTACs improve selectivity for targeted proteins
Acta Materia Medica · 2025
- A multi-dimensional computational framework of drug-induced hepatotoxicity: integrating molecular structure features with disease pathogenesis
Briefings in Bioinformatics · 2025
- Proteome‐Wide Data Guides the Discovery of Lysine‐Targeting Covalent Inhibitors Using DNA‐Encoded Chemical Libraries
Angewandte Chemie · 2025
- MiRNA-21 promotes the migration and proliferation of prostate cancer cells via activating the JAK/STAT pathway
Discover Oncology · 2025
- Kill Two Birds with One Stone: An Efficient and Potent AR CBS-Targeted Degrader Reverses Breast Cancer Resistance via Concurrent AR Degradation and ERα Transcriptional Suppression
Journal of Medicinal Chemistry · 2025
- GPX4-overexpressing mesenchymal stem cell-derived exosomes ameliorate secondary brain injury after intracerebral hemorrhage by inhibiting neuronal ferroptosis
Brain Research · 2025
- Bavdegalutamide (ARV-110): a potent PROTAC androgen receptor degrader for the treatment of metastatic-castration resistant prostate cancer
Elsevier eBooks · 2024
- Buyang Huanwu Decoction in Inhibiting Pathological Vascular Remodeling Through the TGFBR1 Signaling Pathway
SSRN Electronic Journal · 2024
- Targeting androgen receptor degradation with PROTACs from bench to bedside
Biomedicine & Pharmacotherapy · 2022
- Journal of Medicinal Chemistry×12
- Neoplasia×4
- Cancer Research×3
- Acta Materia Medica×2
- MedComm×2
- Bo Wen
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Tianfeng Xu
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Hoda Metwally
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Dmitry Borkin
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Mi Wang
Biochemistry, Genetics and Molecular Biology · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile